EDIT Earnings Editas Medicine, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–28 of 28
| Q2 2026 | 2026-06-30 | -0.40 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.26 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -1.80 | 2026-03-09 | 10-K |
| Q3 2025 | 2025-09-30 | -1.80 | 2025-11-10 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.54 | 2026-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.92 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -2.88 | 2026-03-09 | 10-K |
| Q3 2025 | 2024-09-30 | -2.33 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.58 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.76 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -2.02 | 2025-03-05 | 10-K |
| Q3 2024 | 2023-09-30 | -1.81 | 2024-11-04 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.27 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.71 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -3.21 | 2025-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -2.33 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.52 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.74 | 2023-05-05 | 10-Q |
| FY 2023 | 2021-12-31 | -2.85 | 2024-02-28 | 10-K |
| Q3 2022 | 2021-09-30 | -2.24 | 2022-11-02 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.67 | 2022-08-03 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.86 | 2022-05-04 | 10-Q |
| FY 2022 | 2020-12-31 | -1.98 | 2023-02-22 | 10-K |
| Q3 2021 | 2020-09-30 | -0.93 | 2021-11-09 | 10-Q |
| FY 2020 | 2020-06-30 | -0.43 | 2021-02-26 | 10-K |
| FY 2020 | 2020-03-31 | -0.69 | 2021-02-26 | 10-K |
| FY 2021 | 2019-12-31 | -2.68 | 2022-02-24 | 10-K |
| Q3 2020 | 2019-09-30 | -1.95 | 2020-11-06 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.